American Society of Interventional Pain Physicians | December 13, 2017

The American Society of Interventional Pain Physicians will hold its 20th Annual Meeting March 15-17, 2018 in Orlando, Florida at Marriott Orlando World Center.

March 15, 2018

Raj-Racz Distinguished Lecture Series
  • Mesenchymal Stem Cells: Today, Tomorrow, and Future of Pain Management: Arnold Caplan, PhD
  • Evidence Synthesis in IPM: Evolution of EBM or Death of Expertise and Truth: Laxmaiah Manchikanti, MD

Best Practices in Pain Management in the Context of Addressing the National Opioid Epidemic
  • Current State of Opioid Epidemic: Laxmaiah Manchikanti, MD
  • Turning the Tide on the Opioid Tsunami Crisis: Understanding Pain, Policy, Opioids and Solutions: Anita Gupta, DO, PharmD
  • Addressing National Opioid Epidemic: Jerome Adams, MD, Surgeon General
  • The Opioid Crisis and Pain Management: Vanila Singh, MD

Moderator: Peter Staats, MD, Laxmaiah Manchikanti, MD, Anita Gupta, MD, PharmD, Vanila Singh, MD
Jerome Adams, MD, Surgeon General

  • Resident/Fellow Section
  • Regenerative Medicine
  • Emerging Concepts in Interventional Pain Management
  • Society of Interventional Pain Management Surgery Centers
  • Abstract session
  • Endoscopic Lumbar Decompression
  • Current Concepts in IPM
  • Neuromodulation

March 16, 2018

Manchikanti Distinguished Lecture Series
  • State of Health Care in the US: Past, Present, and Future: Robert Laszewski
  • Health Care Advocacy: ASIPP Involvement with Grass Roots Advocacy: Ed Whitfield
  • Health Care Reform: A View from Washington: Tim Hutchinson

Moderator: Joshua Hirsch, MD
Robert Laszewski, Ed Whitfield, Tim Hutchinson, Laxmaiah Manchikanti, MD, Amol Soin, MD

Best Practices in IPM
  • Advances in Neuromodulation: Ricardo Vallejo, MD
  • Shared Research and Entrepreneurship for Preservation of Interventional Pain Management: Amol Soin, MD
  • Evolution of ASIPP: Standiford Helm, MD
  • What Can Members Do to Preserve IPM: Citizenship: Dharam Mann, MD

  • Resident/Fellow Session
  • Compliance, Billing and Coding
  • Opioids
  • Emerging Concepts in IPM
  • Session for Spouses
  • Managing Spinal Stenosis Beyond Epidurals: The Role of Interventionalist
  • Dry Needling
  • Imaging for Interventionalists
  • Research and Publications in Interventional Pain Management as Part of Your Practice

March 17, 2018

Senator Cassidy and other keynotes and 8 panel discussions on various subjects of interventional pain management until 5 pm.
ASIPP is Pleased to announce Dike Drummond, the Happy MD, as a Keynote Speaker at the Annual Meeting
Dike Drummond MD, CEO
Physician Coach and Healthcare Speaker

Dike Drummond MD is a Mayo trained Family Practice Physician and the leading coach, trainer and consultant on ...

  • The prevention of burnout in individual physicians
  • The realization of the Quadruple Aim in healthcare organizations

Dr. Drummond is a Mayo trained family doctor, professional coach, author, speaker and trainer whose sole professional focus since 2011 has been addressing the modern burnout epidemic in physicians.

He has two keynote speeches during the General Session on Saturday

8:30am – 10:00am               
Burnout Proof Live Workshop: Lower Stress Levels, Build More Life Balance and a More Ideal Practice with Practical Tools to Recognize and Prevent Burnout

1:00pm – 2:00pm               
The Quadruple Aim Blueprint: Four Steps to Proactive, Organization-Wide Burnout Prevention Program
Start Planning NOW!
ASIPP Abstract Submission for 2018 Annual Meeting is Open

This year, we will be making significant changes to the Abstract and Poster Sessions. Submissions will be in two categories: Resident/Fellow and Physician.  Selected posters will be on display for all meeting participants during all breaks and meal times.
The Abstract Committee will select the top 25 for publication in Pain Physician and of those 10 will be selected for Abstract presentation and judging during the Annual Meeting. The top 3 will receive cash prizes.

Most MedPAC Members Happy to Ditch MIPS Payment Program
WASHINGTON -- Momentum appeared to be growing on Thursday for a proposal from the Medicare Payment Advisory Commission (MedPAC) to get rid of the Merit-Based Incentive Payment System (MIPS) for reimbursing physicians who see Medicare patients.

"We need to act on this now," MedPAC staff member Kate Bloniarz told the commissioners. She added that clinicians will start reporting their quality data this year for reimbursement in 2019. "The longer the payments go out, the more there will be an established [group] of clinicians receiving really high payment adjustments who will resist changes to the program."

Don’t Get Left Behind in Health-Care Deal Frenzy

The race to consolidate health-care services is accelerating.

The latest came Wednesday morning:  UnitedHealth Group announced the acquisition of DaVita Medical Group , one of the country’s largest collections of physician practices for $4.9 billion in cash.

UnitedHealth shares barely budged in early trading, since the acquisition will represent a tiny fraction of the insurance giant’s annual revenue and doesn’t stretch the company’s financial resources. But the deal significantly expands UnitedHealth’s primary care operations, consistent with the company’s goal of owning primary and walk-in medical practices accessible to 60% of the U.S. population by 2025.

Access to this article may be limited.

Interventional Pain Management Reports is an Open Access online journal, a peer-reviews journal dedicated to the publication of case reports, brief commentaries and reviews and letters to the editor. It is a peer-reviewed journal written by and directed to an audience of interventional pain physicians, clinicians and basic scientists with an interest in interventional pain management and pain medicine. 

Interventional Pain Management Reports is an official publication of the American Society of Interventional Pain Physicians (ASIPP) and is a sister publication of Pain Physician . Interventional Pain Management Reports Interventional Pain Management Reports is an open access journal, available online with free full manuscripts.  

The benefits of publishing in an open access journal that has a corresponding
print edition journal are:  
  • Your article will have the potential to obtain more citations.
  • Your article will be peer-reviewed and published faster than other journals.
  • Your article can be read by a potentially much larger audience compared with traditional subscription-only journals.  
  • Open Access journals are FREE to view, download and to print.

So submit today your:
  • Case Reports
  • Technical Reports
  • Editorials
  • Short Perspectives

Click HERE to submit
Brooklyn Prosecutors Charge 20 in $146 Million Health-Care Fraud

Brooklyn prosecutors said Tuesday that they charged 20 people and 14 corporations in a $146 million fraud scheme, calling it the biggest health-care case in their office’s history.
The defendants paid patients to come to clinics, where they received unnecessary tests that were subsequently billed to Medicare and Medicaid, prosecutors said. The defendants then spent the proceeds on real estate, luxury shopping sprees and lavish vacations, according to an indictment.

Access to this article may be limited
Hydrocodone Prodrug May Reduce Abuse Potential
Intranasal administration of benzhydrocodone, a prodrug of hydrocodone, was shown to be associated with reduced hydrocodone exposure and decreased  drug liking , compared with hydrocodone bitartrate, according to a recent study published in  Pain Medicine .

In this single-center crossover study, healthy nondependent recreational opioid users were randomly assigned to receive the active pharmaceutical ingredient (API) of intranasal benzhydrocodone (13.34 mg) followed by hydrocodone bitartrate API (15.0 mg), or the opposite sequence. A 72-hour washout period separated each treatment. Hydrocodone plasma concentration and drug liking scores based on a bipolar visual analog scale were compared between groups.

Peripheral Nerve Blocks Reduce Postoperative Pain After Hip Replacement

Peripheral nerve blocks may reduce postoperative pain and increase patient satisfaction in adults undergoing elective primary hip replacement, according to the results of a systematic review published in  Cochrane Database of Systematic Reviews.

To evaluate the benefits and harms of nerve blocks after elective hip replacement, a systematic review of 51 randomized controlled trials (n=2793) was performed. A total of 45 randomized controlled trials were included in the meta-analyses, which compared  peripheral nerve block  (n=1288) with any other pain management option (n=1203).

Based on moderate-quality evidence, peripheral nerve blocks were shown to reduce pain at rest on arrival in the postoperative care unit compared with systemic analgesia alone (standard mean difference [SMD], -1.12; 9 trials; 95% CI, -1.67 to -0.56; n=429; equivalent to a reduction of 3.2 points in pain level on a 0 to 10 scale).

ND’s Substance Abuse Program Addresses Rural Area Treatment

Philadelphia—Over the past three years, North Dakota has successfully implemented a Screening, Brief Intervention, and Referral to Treatment (SBIRT) program for substance use disorder that has helped combat the state’s growing opioid problem.

“In clinical practice, it takes only three to five minutes to do an assessment and screening for substance use disorder in any patient,” said Jacqueline Roberts, DNP, clinical assistant professor of nursing at the University of North Dakota, in Grand Forks. “This can be done in any setting. We have given the training to social workers, nurses, police officers, dentists and pharmacists, as well as other health professionals.”

FDA Accepts New Drug Application for Novel Buprenorphine Sublingual Spray

Insys Therapeutics announced that the Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for its novel buprenorphine sublingual spray for the management of moderate-to-severe acute pain. 

The NDA submission was supported by data from a study that met its primary efficacy endpoint in addition to several pharmacokinetic studies. Recently, the Company finished a 7-day safety and tolerability study among 100 patients for which the data will be submitted to the FDA in early 2018.

On the Importance of Screening for ADHD in Patients With Fibromyalgia

Adult attention deficit hyperactivity disorder (ADHD) frequently co-occurs with fibromyalgia syndrome (FMS) and may negatively affect FMS-related morbidity, according to results from a cross-sectional, observational study published in Pain Medicine.

Investigators screened a total of 123 patients with FMS using the World Health Organization (WHO) Adult ADHD Self Report scale v1.1 to determine the frequency of ADHD in the setting of FMS. The impact of FMS was assessed using the Revised Fibromyalgia Impact Questionnaire (FIQ-R).

Hospital loses tax-exempt status after inking JV with for-profit company

The IRS revoked an acute care hospital's tax-exempt status after the hospital entered into a joint venture agreement with a for-profit company, according to The National Law Review

Various details have been redacted from the recently released final adverse determination letter, including the hospital's name, but the letter is clear that the hospital lost its 501(c)(3) status for entering into a lease agreement in a manner that was incongruent with its tax-exempt status.

According to the IRS, the nonprofit hospital leased its property, land and equipment to the for-profit entity. The hospital also gave control of its operations to the for-profit.

State Society News 
April 18-22, 2018
GSIPP 2018 Annual Meeting
Georgia Society of Interventional Pain Physicians
Thursday, April 18, 2018 - Sunday, April 22, 2018
The Ritz Carlton Reynolds, Lake Oconee

July 19-22, 2018
FSIPP 2018 Annual Meeting, Conference, and Trade Show
Florida Society of Interventional Pain Physicians
One South County Road, Palm Beach, FL 33480

Send in your state society meeting news to Holly Long,
ASIPP | Pain Physician Journal | Phone | Fax | Email